Pharmaceutical giant Roche has successfully operationalised “Agentic AI” to revolutionise its high-stakes patent research, according to a 2026 success story from Dataiku. By moving beyond simple keyword searches to a unified AI interface called Themis PatAI, Roche has turned an exhaustive, manual legal process—comprising over 50,000 cases from the European Patent Office (EPO)—into a streamlined, digital workflow.
The core of this transformation is the shift from months-long development cycles to a matter of days, enabled by Dataiku’s “citizen development” approach. This allows non-technical patent attorneys and paralegals to build and deploy complex AI search flows without traditional IT bottlenecks.
Strategic Impact: Efficiency and Cost-De-risking
Roche’s patent team, based in Basel, faced a rising tide of case law and the need for rapid responses to oppositions and appeals. The deployment of Themis PatAI acts as an orchestrator, routing natural language queries to various sub-agents that handle semantic search, full-text analysis, and internal document lookups via Google Drive.
Editor’s Take: Roche’s implementation is a blueprint for Institutional Knowledge Management. In the pharmaceutical sector, where patents are the primary currency of value, the ability to surface precedents with 100% accuracy is a competitive necessity. By empowering “citizen developers” (attorneys) to build their own tools, Roche has effectively bypassed the “IT wait-list,” saving nearly US$500,000 in consultancy fees alone. For the Malaysian Business audience, this serves as a critical lesson in operational democratisation: the most effective AI tools are often those built by the subject-matter experts who actually use them, provided they have a governed, low-code platform like Dataiku.
Key Performance Indicators (KPIs)
- Time to Market: New GenAI projects now take days, down from months.
- Direct Savings: US$100,000–$250,000 in annual attorney hours saved per case.
- Consultancy Avoidance: US$375,000–$475,000 saved by keeping development in-house.
- Scale: Expanding from 80 European attorneys to potentially 250 globally.